Cite
The industry of therapeutic monoclonal antibodies in Brazil: Public policies as instruments of technology upgrading.
MLA
Silva, Renan G. L.da, et al. “The Industry of Therapeutic Monoclonal Antibodies in Brazil: Public Policies as Instruments of Technology Upgrading.” Science & Public Policy (SPP), vol. 50, no. 1, Feb. 2023, pp. 42–58. EBSCOhost, https://doi.org/10.1093/scipol/scac047.
APA
Silva, R. G. L. da, Fischer, B. B., Schaeffer, P. R., & Novaes, H. M. D. (2023). The industry of therapeutic monoclonal antibodies in Brazil: Public policies as instruments of technology upgrading. Science & Public Policy (SPP), 50(1), 42–58. https://doi.org/10.1093/scipol/scac047
Chicago
Silva, Renan G L da, Bruno B Fischer, Paola R Schaeffer, and Hillegonda M D Novaes. 2023. “The Industry of Therapeutic Monoclonal Antibodies in Brazil: Public Policies as Instruments of Technology Upgrading.” Science & Public Policy (SPP) 50 (1): 42–58. doi:10.1093/scipol/scac047.